Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neha Panjwani

Are Wall Street Analysts Predicting AbbVie Stock Will Climb or Sink?

AbbVie Inc. (ABBV), headquartered in North Chicago, Illinois, is a biopharmaceutical company discovers, develops, manufactures, and sells pharmaceuticals worldwide. Valued at $346.8 billion by market cap, the company discovers and develops medicines and therapies that solve health issues across immunology, oncology, aesthetics, neuroscience, and eye care.

Shares of this drug giant have outperformed the broader market over the past year. ABBV has gained 15% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 8.2%. In 2025, ABBV stock is up 5.3%, surpassing the SPX’s 4.7% decline on a YTD basis. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.